Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- The global burden of TB - 2010
- TB incidence rates - 2010
- Impact of HIV on TB in Africa
- % MDR-TB among new TB cases 1994-2009
- Absolute numbers of reported MDR-TB cases
- 13 top settings with highest % of MDR-TB
- Time trends in TB and MDR-TB
- Countries with at least one XDR-TB case
- Progress towards international targets
- Stop TB strategy and global plan
- The global TB control targets
- Achievements thus far, 2011
- Incidence, prevalence and mortality rates
- Reductions in TB cases and deaths in China
- TB cases and deaths, absolute numbers
- Notifications of MDR-TB increasing
- Case notifications by region, 1990-2010
- Global notifications
- Challenges in 2011
- Challenges in 2011 if we target "elimination"
- Funding required, global plan
- Underfunding persists
- Funding for TB control increasing
- BRICS mostly domestic funding
- HIV testing for TB patients expanding
- CPT and ART for HIV+ TB patients
- Policy on collaborative TB/HIV activities
- Treatment success 87% globally
- TB patients tested for MDR-TB remain low
- Response to M/XDR-TB in 27 HBCs
- Critical steps for prevention and control
- Policy changes are fundamental
- Increasing notifications via PPM
- Increasing case notifications is good
- Limitations of diagnostics, drugs and vaccine
- 2015 MDG target reached but TB not eliminated
- Actions needed
- Tuberculosis control and elimination
- Innovative action needed in 4 spheres
- Population attributable fraction
- Potential impact of new TB vaccines
- A step ahead in diagnosis: introducing GeneXpert
- Roll-out of Xpert MTB/RIF
- Current TB therapy and unmet needs
- Global TB drug pipeline, June 2011
- Conclusions
- Many thanks to all
Topics Covered
- Burden of tuberculosis
- HIV-associated tuberculosis and multidrug-resistant tuberculosis
- Progress towards achievement of international targets
- Challenges in 2012
- Interventions needed in four areas; intensification of core tuberculosis control and care efforts, bold health policies, increased research efforts, and alleviation of socio-economic determinants of tuberculosis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Raviglione, M. (2013, February 28). The international approach to the control of tuberculosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/TLAV1259.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Mario Raviglione has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.